Memorial Hospital of Rhode Island is a 294-bed community hospital serving the Blackstone Valley of Rhode Island and Southeastern Massachusetts. The hospital is a teaching affiliate of The Warren Alpert Medical School of Brown University and the chief site for the medical school's primary care academic program housed in the Center for Primary Care.

Our main campus is in Pawtucket, RI, and our affiliates provide primary and ambulatory care services at sites in Quality Hill, Plainville, Barrington and Central Falls. Memorial is also home to a state-of-the-art cancer treatment facility in Pawtucket.

At Memorial Hospital of Rhode Island, we know that finding a physician to meet your individual needs can be a challenge. Our Physician Referral Service offers a personalized approach to match your needs with a physician's expertise. For more information, please call 1-800-MHRIDOC (1-800-647-4362)

Annual Report 2007
Annual Report 2006
Update: Summer Issue 2008
Update: Winter Issue 2008
Update: Fall Issue 2007

Simple DNA tests may improve the success rate for smoking cessation. That's one of the findings of a major research study published in the June 2008 issue of the Archives of General Psychiatry.

Sean P. David, MD, SM, DPhil, the director of Memorial Hospital's Primary Care Genetics Lab and Translational Research Center, and an assistant professor of family medicine at Brown University, is a co-author of the report. He says, "This is "the first genome-wide study of the efficacy of bupropion (Zyban) and nicotine replacement therapy (NRT) for smoking cessation."

To learn more, see the television video
and press releases

The research team used a technique known as genome-wide association scans to compare DNA extracted from the blood of smokers who were either successful or unsuccessful in quitting using bupropion or NRT in the form of a nicotine patch or nasal spray. Certain clusters of gene variants were present more frequently in the successful quitters. The genetic variations in those who were successfully treated with bupropion were different from those who were helped by NRT.

Raymond Niaura, PhD, professor of psychiatry and human behavior at Brown, was the principal investigator of the Rhode Island component of the study. Duke University and the University of Pennsylvania were the other locations for the study.